Gene · 5798
Papers3,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Screening and care for preclinical stage 1-2 type 1 diabetes in first-degree relatives: French expert position statement. | Diabetes Metab | 2025 | 39675522 | PubTator, text mining | PubMed |
| Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes. | Diabetologia | 2025 | 39670998 | PubTator, text mining | PubMed |
| Age and sex mark clinical differences in the presentation of pediatric type 1 diabetes mellitus. | J Pediatr Endocrinol Metab | 2025 | 39602489 | PubTator, text mining | PubMed |
| Looking back at the TEDDY study: lessons and future directions. | Nat Rev Endocrinol | 2025 | 39496810 | PubTator, text mining | PubMed |
| Characterization of Turner Syndrome-associated Diabetes Mellitus. | J Clin Endocrinol Metab | 2025 | 38961758 | PubTator, text mining | PubMed |
| Identification of Prognostic Markers of Glioblastoma through Bioinformatics Analysis. | Altern Ther Health Med | 2025 | 38639614 | PubTator, text mining | PubMed |
Estimation of Human Islet Antigen Insulinoma-Associated-2 Autoantibody and Zinc Transporter 8 Autoantibody levels in saliva and serum in generalized periodontitis patients with and without Type 2 Diabetes mellitus - A cross-sectional study. | Stomatologija | 2024 | 40493952 | PubTator, text mining | PubMed |
| Changes in CD4+CD25HIGH T cells and TGFβ1 levels in different stages of adult-onset type 1 diabetes. | J Med Biochem | 2024 | 39876913 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model based on oxidative stress-related genes in non-small cell lung cancer (NSCLC): predicting patient outcomes and therapy responses. | Transl Lung Cancer Res | 2024 | 39669999 | PubTator, text mining | PubMed |
| Single-Stranded Variable Fragment Gene Libraries Built for Phage Display: An Updated Review of Design, Selection and Application. | J Microbiol Biotechnol | 2024 | 39631781 | PubTator, text mining | PubMed |
| Bioinformatic analysis constructs an optimal prognostic index for survival-related variables (OPISV) based on whole-genome expression data in Glioblastoma. | Int J Biol Macromol | 2024 | 39505178 | PubTator, text mining | PubMed |
| Treatment switch from multiple daily insulin injections to sulphonylureas in an African young adult diagnosed with HNF1A MODY: a case report. | J Med Case Rep | 2024 | 39420387 | PubTator, text mining | PubMed |
| Experimental study on shear mechanical properties of concrete joints under different unloading stress paths. | PLoS One | 2024 | 39298525 | PubTator, text mining | PubMed |
| A Novel Shunt Zigzag Double-Tap Low-Harmonic Multi-Pulse Rectifier Based on a Three-Stage Power Electronic Phase-Shifting Transformer. | Sensors (Basel) | 2024 | 39275481 | PubTator, text mining | PubMed |
| A Case of Type 2 Diabetes Mellitus Revealed Transient Positivity of Glutamic Acid Decarboxylase (GAD) Antibodies Following Immunoglobulin Administrations. | Cureus | 2024 | 39247010 | PubTator, text mining | PubMed |
| Autoantibodies against beta cells to predict early insulin requirements in pediatric patients with clinically diagnosed type 2 diabetes. | World J Diabetes | 2024 | 39192864 | PubTator, text mining | PubMed |
| Diabetes and CFAP126 gene mutation; are they really linked together? | J Pediatr Endocrinol Metab | 2024 | 39165147 | PubTator, text mining | PubMed |
| A case of rapidly progressive insulin-dependent diabetes mellitus without islet autoantibodies developed over two years after the first dose of nivolumab. | Diabetol Int | 2024 | 39101192 | PubTator, text mining | PubMed |
| Frequency of C-peptide and antibody levels (anti GAD, Islet cell antibodies, insulin auto antibodies) in children of Pakistan with Type-1 diabetes. | Pak J Med Sci | 2024 | 38952492 | PubTator, text mining | PubMed |
| Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07). | Diabetes Care | 2024 | 38949847 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5798/papers?page=5